Skip to main content
Clinical Trials/NCT03365622
NCT03365622
Completed
Phase 4

Randomized, Double-Blind Clinical Study Evaluating Efficacy of Intravenous Versus Enteric Acetaminophen in Donor Nephrectomy and Robot-Assisted, Laparoscopic Nephrectomy.

University of Rochester1 site in 1 country214 target enrollmentAugust 8, 2018

Overview

Phase
Phase 4
Intervention
Acetaminophen
Conditions
Nephrectomy
Sponsor
University of Rochester
Enrollment
214
Locations
1
Primary Endpoint
Total Opioid Dose (MME) Used in 24 Hours
Status
Completed
Last Updated
10 months ago

Overview

Brief Summary

The aim of this study is to determine whether intravenous acetaminophen compared to enteric acetaminophen offers increased efficacy in patients who are scheduled for laparoscopic donor nephrectomy and for patients scheduled for robot-assisted, laparoscopic nephrectomy for cancer at the University of Rochester Medical Center. The standard surgical and post-operative care, including post-operative pain management will not be altered.

Registry
clinicaltrials.gov
Start Date
August 8, 2018
End Date
April 10, 2024
Last Updated
10 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Joseph W Dooley, MD

Associate Professor

University of Rochester

Eligibility Criteria

Inclusion Criteria

  • Be at least 18 years old
  • Be scheduled for donor nephrectomy or robot-assisted, laparoscopic nephrectomy for cancer at University of Rochester Medical Center
  • Have cognitive ability to verbally rate their pain on the Numeric Rating Scale (NRS).

Exclusion Criteria

  • Age younger than 18 years old or older than 90 years old
  • Pregnancy (Pre-operative pregnancy test is standard of care for all elective operating room cases)
  • Weight less than 50 kg
  • Epidural use
  • History of known liver disease.
  • Patient unable to take enteral medications.
  • Be taking opioid medications chronically.

Arms & Interventions

placebo IV (normal saline) + oral acetaminophen

Intervention: Acetaminophen

IV acetaminophen and placebo pills

Intervention: Acetaminophen

IV acetaminophen and placebo pills

Intervention: Placebo Oral Tablet

placebo IV (normal saline) + oral acetaminophen

Intervention: Placebos

Outcomes

Primary Outcomes

Total Opioid Dose (MME) Used in 24 Hours

Time Frame: 20 to 24 hours post-operatively

Total opiate dose used from the study start (when the first dose of acetaminophen is administered in the pre-anesthesia holding area) to 24 hours post-operatively (in morphine milligram equivalents (MME)).This will include opiates administered intra-operatively.

Secondary Outcomes

  • Average Surgical Pain Intensity(1-2 hours post-operatively)
  • Mean Inspiratory Capacity(20-24 hours post-operatively)
  • Dynamic Pain Score During Incentive Spirometer Use(20-24 hours post-operatively)
  • Surgical Pain Score During the 20-24 Hour Assessment(20-24 hours post-operatively)
  • Time to First Narcotic Use(24 hours post-operatively)
  • Number of Participants With Nausea(24 hours post-operatively)
  • Time to Discharge From Post-anesthesia Care Unit(24 hours)
  • Time to Hospital Discharge(30 days)

Study Sites (1)

Loading locations...

Similar Trials